Trial Profile
Assessing the Efficacy and Tolerability of Changing to DuoTrav (Travoprost 0.004%/Timolol 0.5% BAK-Free Fixed Combination), as Replacement Therapy in Patients Previously on Prior Prostaglandin Fixed Combination
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Travoprost/timolol (Primary)
- Indications Open-angle glaucoma
- Focus Therapeutic Use
- Sponsors Alcon
- 08 Apr 2015 New trial record